SI-BONE, INC. (SIBN) Operating Margin
- Operating margin · 12 months: Value -8.31%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -8.31% | Operating income / revenue. Period ending 2026-06-30. $-17.75M ÷ $213.60M × 100 ≈ -8.31% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -17.75M USD | Operating Income (Loss) |
| Revenue | 213.60M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 43.73M USD | Cost of Goods and Services Sold |
| Research and development | 18.02M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-17.75M | $213.60M | $43.73M | $18.02M | (m) | -8.31% |
| 2026-03-31 | $-19.94M | $206.22M | $42.09M | $17.11M | (m) | -9.67% |
| 2025-12-31 | $-22.33M | $200.93M | $41.05M | $17.45M | (m) | -11.11% |
| 2025-09-30 | $-25.36M | $193.58M | $39.45M | $16.95M | (m) | -13.10% |
| 2025-06-30 | $-27.61M | $185.26M | $38.08M | $16.71M | (m) | -14.90% |
| 2025-03-31 | $-30.68M | $176.60M | $36.65M | $16.75M | (m) | -17.38% |
| 2024-12-31 | $-35.25M | $167.18M | $35.06M | $16.56M | (m) | -21.08% |
| 2024-09-30 | $-42.26M | $157.03M | $35.02M | $16.85M | (m) | -26.91% |
| 2024-06-30 | $-45.80M | $150.71M | $33.62M | $16.78M | (m) | -30.39% |
| 2024-03-31 | $-47.68M | $144.04M | $31.54M | $16.08M | (m) | -33.10% |
| 2023-12-31 | $-46.93M | $138.89M | $29.47M | $15.03M | (m) | -33.79% |
| 2023-09-30 | $-45.72M | $131.98M | $24.37M | $14.35M | (m) | -34.64% |
| 2023-06-30 | $-48.12M | $124.40M | $21.50M | $13.52M | (m) | -38.68% |
| 2023-03-31 | $-54.03M | $116.68M | $18.65M | $13.34M | (m) | -46.31% |
| 2022-12-31 | $-59.61M | $106.41M | $15.71M | $13.63M | (m) | -56.02% |
| 2022-09-30 | $-62.25M | $99.69M | $13.99M | $13.20M | (m) | -62.44% |
| 2022-06-30 | $-61.88M | $95.54M | $12.30M | $13.39M | (m) | -64.77% |
| 2022-03-31 | $-56.96M | $92.15M | $11.21M | $13.07M | (m) | -61.82% |
| 2021-12-31 | $-51.67M | $90.15M | $10.43M | $12.44M | (m) | -57.31% |
| 2021-09-30 | $-45.61M | $87.07M | $9.33M | $11.82M | (m) | -52.39% |
| 2021-06-30 | $-41.09M | $85.15M | $9.43M | $11.31M | (m) | -48.25% |
| 2021-03-31 | $-38.26M | $77.01M | $9.17M | $10.32M | (m) | -49.68% |
| 2020-12-31 | $-38.57M | $73.39M | $8.90M | $9.46M | (m) | -52.55% |
| 2020-09-30 | $-39.18M | $71.05M | $8.67M | $8.81M | (m) | -55.14% |
| 2020-06-30 | $-41.09M | $66.86M | $7.72M | $7.91M | (m) | -61.45% |
| 2020-03-31 | $-39.09M | $69.13M | $7.20M | $7.69M | (m) | -56.54% |
| 2019-12-31 | $-36.00M | $67.30M | $6.79M | $7.28M | (m) | -53.50% |
| 2019-09-30 | $-31.82M | $63.11M | $6.13M | $7.00M | (m) | -50.42% |
| 2019-06-30 | $-24.29M | $60.31M | $5.72M | $6.50M | (m) | -40.27% |
| 2019-03-31 | $-17.85M | $57.66M | $5.31M | $5.85M | (m) | -30.95% |
| 2018-12-31 | $-11.96M | $55.38M | $4.83M | $5.38M | (m) | -21.61% |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $-17.35M | $47.98M | $5.11M | $5.51M | (m) | -36.16% |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |